These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7528880)

  • 1. Enhancement of cytogenetic damage and of antineoplastic effect in lymphoid L1210 leukemia cells treated with prostaglandin E2 and cyclophosphamide in vivo.
    Mourelatos D; Mioglou E; Kristi Z; Dozi-Vassiliades J
    Mutat Res; 1995 Jan; 326(1):125-9. PubMed ID: 7528880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of antineoplastic effect and attenuation of sister chromatid exchanges by prostaglandin E2 in Ehrlich ascites tumour cells treated with cyclophosphamide in vivo.
    Mourelatos D; Kritsi Z; Mioglou E; Dozi-Vassiliades J
    Prostaglandins Leukot Essent Fatty Acids; 1993 Sep; 49(3):707-10. PubMed ID: 8248278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of cytogenetic damage and of antineoplastic effect by caffeine in Ehrlich ascites tumor cells treated with cyclophosphamide in vivo.
    Mourelatos D; Dozi-Vassiliades J; Kotsis A; Gourtsas C
    Cancer Res; 1988 Mar; 48(5):1129-31. PubMed ID: 3342394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on Salmonella mutagenicity and on cytogenetic and antineoplastic effects induced by cyclophosphamide and 3-aminobenzamide in cells of three transplantable tumours in vivo.
    Eliopoulos P; Mourelatos D; Dozi-Vassiliades J
    Mutat Res; 1995 Apr; 342(3-4):141-6. PubMed ID: 7715615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and pharmacologic study of therapeutic synergism with cyclophosphamide plus methotrexate in murine L1210 leukemia.
    Klubes P; Cerna I
    Cancer Treat Rep; 1981; 65(1-2):107-14. PubMed ID: 7226161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of sister chromatid exchange induction and antitumor effects by homo-aza-steroidal esters of [p-[bis(2-chloroethyl)amino]phenyl]butyric acid.
    Camoutsis C; Catsoulacos D; Karayiann V; Papageorgiou A; Mourelatos D; Mioglou E; Kritsi Z; Nikolaropoulos S
    Cancer Detect Prev; 2001; 25(6):558-64. PubMed ID: 12132876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J; Robak T; Warzocha K; Grieb P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of current alkylating agents with a homo-aza-steroidal ester for antineoplastic activity.
    Catsoulacos P; Papageorgiou A; Margarity E; Mourelatos D; Mioglou E
    Oncology; 1994; 51(1):74-8. PubMed ID: 8265107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical studies on NSC290205 aza-steroid alkylator activity in combination with adriamycin against lymphoid leukaemia.
    Trafalis DT; Tsavdaridis D; Camoutsis C; Karayiani V; Mourelatos D; Dalezis P; Athanassiou A; Pangalis GA; Papageorgiou A
    Br J Haematol; 2005 Feb; 128(3):343-50. PubMed ID: 15667536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenic and nondividing mafosfamide-treated L 1210 cells--comparison of lines resistant and nonresistant to cyclophosphamide.
    Kawalec M; Hoser G; Skórski T; Kawiak J
    Folia Histochem Cytobiol; 1993; 31(2):63-6. PubMed ID: 8405569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
    Avery TL; Roberts D
    Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological concepts and the combination of cyclophosphamide with 5-aza-2'-deoxycytidine on L1210 in vivo.
    Zaharko DS
    J Immunopharmacol; 1985; 7(2):195-202. PubMed ID: 2411821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New application of a stabilized active cyclophosphamide derivative (mafosfamide, ASTA Z 7654)--immunogenic properties of lymphatic leukemia L 1210 cells treated in vitro with the drug.
    Skórski T; Kawalec M
    Invest New Drugs; 1987; 5(2):167-9. PubMed ID: 3654151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of immunotherapy with cyclophosphamide/actinomycin D chemotherapy potentiates antileukemic effect and reduces toxicity in a L1210 leukemia model in mice.
    Lasek W; Sora M; Wańkowicz A; Jakóbisiak M
    Cancer Lett; 1995 Feb; 89(1):137-43. PubMed ID: 7882296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
    Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
    Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of benzylpenicillin and doxycycline on toxicity and antineoplastic action of cyclophosphamide and methotrexate in mice].
    Pakulska W
    Acta Pol Pharm; 1992; 49(1-2):35-40. PubMed ID: 8769079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of the therapeutic activity of cyclophosphamide by an original N-acyldehydroalanine.
    Allemon AM; Buc Calderon P; Roberfroid M
    Drugs Exp Clin Res; 1987; 13(6):359-65. PubMed ID: 3652925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim.
    Stoychkov JN; Milushev AS; Todorov DK
    Neoplasma; 1980; 27(1):33-6. PubMed ID: 6892839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Potentiation of the antitumor action of alkylating compounds by amphotericin B].
    Iaremenko KV; Eremeeva AA; Tereshin IM
    Antibiotiki; 1977; 22(2):153-8. PubMed ID: 404957
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.